globaltoronto

On March 7th, 2013 Global News Toronto launched "Inside Epilepsy," a series highlighting what it means to live with a seizure disorder.  Thanks to the courage of Global News Reporter, Mark McAllister, and other individuals for sharing their personal experiences they are shining the light and stamping out stigma for those living with epilepsy.

 

Below are the links for the video series.  Please take the time to check these out and learn how you can help educate others on epilepsy to show these individuals they are not alone.

 

Inside Epilepsy: Mark McAllister shares his story

Episode 1: Patients turn to brain surgery for

...

no picture

Pfizer has reported that they are experiencing a shortage of Neurontin tablets (600 mg) which is expected to be resolved by March 15, 2013.

 

Epilepsy Ontario contacted Pfizer's customer service department and learned that all other strengths of Neurontin are available: 100 mg, 300 mg and 400 mg capsules, and 800 mg tablets.

 

This temporary shortage appears to be restricted to the 600 mg Neurontin tablets only. There is no indication that any other brands or dosages of gabapentin are affected. If you take Neurontin 600 mg tablets, contact your pharmacist for more information and to ask whether they have the medication in stock.

 

For additional information visit the

Canadian Drug Shortages Database.

Pfizer Canada Inc., Customer Service Department 1-888-275-9938

(Adapted from Epilepsy Ontario - Voices of Epilepsy)  

 

obclrcertificate

The 2013 OBCL Epilepsy Scholarship Awards are proud to offer up to five $1,000 scholarships to students across Ontario who are living with epilepsy.  Students have the opportunity to apply for awards in the follow categories:

 

1. Continuing Studies Award

2. President's Award of Distinction

3. OBCL General Scholarship Awards

 

Download the About the Award PDF below to find out if you're eligible.  If so, download and complete the OBCL Epilepsy Scholarship Awards Application available below.

1 onfi clobazam

After a province-wide scarcity of the anti-seizure medication Clobazam, the Canadian Epilepsy Alliance has been working diligently to address to shortage and provide those living with epilepsy with viable alternatives while the issue is being resolved.

 

Click here to read about medical recommendations for adults with epilepsy currently taking Clobazam, as per information received from  Dr. J.C. Martin del Campo (University Health Network) and Dr. Jorge Burneo (London Health Sciences Centre).

clobozamimage

Clobozam/Drug ShortageIn a new national survey of more than 1,070 members of the Canadian Pharmacists Association, Canadian Medical Association and the Canadian Society of Hospital Pharmacies released January 14th, 2013, statistics reveal startling findings:

 

  • - 66% of doctors reported that a national drug shortage worsened since 2010
  • - 94% of pharmacists reported difficulty locating medication for a patient in the previous week
  • - 41% of pharmacists surveyed said drug shortages compromised their patients' health

 

Click hereto read the full story and to watch a video featuring a patient with epilepsy

...

Website Designed and Hosted by The Social Business